Oracea, Hartkapseln mit veränderter Wirkstofffreisetzung

7680616860019 CH-61686 Hartkapseln mit veränderter Wirkstofffreisetzung

Associated product:

ORACEA caps ret 40 mg 28 pce
Oracea, Hartkapseln mit veränderter Wirkstofffreisetzung
Oracea, Hartkapseln mit veränderter Wirkstofffreisetzung
Oracea, Hartkapseln mit veränderter Wirkstofffreisetzung
1 / 3
google

Article details

Package size
28
Selling units
28
Measure
Kapsel(n)
Galenic form
Hartkapseln mit veränderter Wirkstofffreisetzung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
31/12/2021
Patient information leaflet
Français
31/12/2021
Patient information leaflet
Italien
31/12/2021
Summary of Product Characteristics
Allemand
30/06/2021
Summary of Product Characteristics
Français
30/06/2021
Summary of Product Characteristics
Italien
30/06/2021

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
41.62 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
150.36 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FIMDK
(N/A)
- Substance HBESI
(N/A)
- Substance FIMDK
(N/A)
- Substance FIMDK

Reimbursement information

Public price
CHF 33.90
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2013

Authorization holder

Galderma SA

6300 Zug

Authorization information

Swissmedic authorization number
61686
Drug name
Oracea, Hartkapseln mit veränderter Wirkstofffreisetzung
Galenic form
KAHA
ATC Code
J01AA02
Authorization status
Z
Dispensing category
A
First authorization
15/03/2012
Authorization expiration date
31/12/9999
IT Number
08.01.5.
Domain
Human medicine
Field of application
Rosazea

Package details

Description (FR)
ORACEA caps ret 40 mg 28 pce
Description (DE)
ORACEA Ret Kaps 40 mg 28 Stk
Market launch
15/03/2012
Narcotic (BTM)
No

Available generics (10)

Doxyclin, Tabletten
GTIN: 7680440000605
CHF 13.35
View
Doxyclin, Tabletten
GTIN: 7680440000612
CHF 31.85
View
Doxyclin, Tabletten
GTIN: 7680440000339
CHF 16.45
View
Doxycyclin-Mepha, Tabletten
GTIN: 7680659520017
CHF 25.55
View
Doxycyclin-Mepha, Tabletten
GTIN: 7680659520024
CHF 14.15
View
Doxycyclin-Mepha, Tabletten
GTIN: 7680659520031
CHF 17.60
View
Doxylag 100, capsules
GTIN: 7680426880016
CHF 14.25
View
Doxylag 100, capsules
GTIN: 7680426880023
CHF 38.60
View
Doxylag 100, capsules
GTIN: 7680426880108
CHF 13.30
View
Doxysol, Tabletten
GTIN: 7680507480302
CHF 13.30
View

Other package sizes (1)

ORACEA caps ret 40 mg 56 pce
56 KAP
GTIN: 7680616860026
View